<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2019-12-02">
  <drugbank-id primary="true">DB11226</drugbank-id>
  <name>Ethylhexyl methoxycrylene</name>
  <description>Ethylhexyl methoxycrylene is a photostabilizer that preserves the effectiveness of UV filters by interacting with both the singlet and triplet states [F104]. It returns UV filters to their ground states without absorbing sunlight [F104]. It is used as a solvent for crystalline UV filters and is easily emulsified and suitable for use in various lotions, creams, sprays, sticks, and gel formulations [F104]. It currently enjoys regional approvals in Canada, the EU, and the US [L2847].</description>
  <cas-number>947753-66-4</cas-number>
  <unii>S3KFG6Q5X8</unii>
  <average-mass>391.511</average-mass>
  <monoisotopic-mass>391.214743798</monoisotopic-mass>
  <groups>
    <group>approved</group>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A33135</ref-id>
        <pubmed-id>23136952</pubmed-id>
        <citation>Kikuchi A, Hata Y, Kumasaka R, Nanbu Y, Yagi M: Photoexcited singlet and triplet states of a UV absorber ethylhexyl methoxycrylene. Photochem Photobiol. 2013 May-Jun;89(3):523-8. doi: 10.1111/php.12017. Epub 2012 Dec 17.</citation>
      </article>
      <article>
        <ref-id>A33070</ref-id>
        <pubmed-id>11702366</pubmed-id>
        <citation>Benson HA: Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol. 2000 Jul-Aug;1(4):217-24.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2847</ref-id>
        <title>Hallstar: SolaStay S1 Product Profile</title>
        <url>https://www.hallstar.com/product/solastay-s1/</url>
      </link>
    </links>
    <attachments>
      <attachment>
        <ref-id>F101</ref-id>
        <title>NATIONAL INDUSTRIAL CHEMICALS NOTIFICATION AND ASSESSMENT SCHEME (NICNAS) Public Report On: Ethylhexyl Methoxycrylene</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/101/original/STD-1444-FR_Final.docx?1527109345</url>
      </attachment>
      <attachment>
        <ref-id>F103</ref-id>
        <title>Sunscreen Photostability 101</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/103/original/SunscreenPhotostability101.pdf?1527110179</url>
      </attachment>
      <attachment>
        <ref-id>F104</ref-id>
        <title>Hallstar Sun Care Advanced Formulated Solutions Brochure</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/104/original/Hallstar_Sun_Care_Brochure_2017.pdf?1527110241</url>
      </attachment>
    </attachments>
  </general-references>
  <synthesis-reference/>
  <indication>Ethylhexyl methoxycrylene is employed as a photostabilizing agent in various sunscreen products [L2847].</indication>
  <pharmacodynamics>As an active ingredient in topical sunscreen products, ethylhexyl methoxycrylene is applied directly onto human skin where it acts as a critical component for conferring photostability to the product's other constituent ingredients, protecting the product as a whole from deterioration in the sunlight [L2847]. Additionally, considering the high log Pow value (6.05-6.32) and low water solubility, dermal absorption of ethylhexyl methoxycrylene is expected to be low. This is supported by a dermal absorption of less than 5% observed for an acceptable analogue of the notified chemical [F101]. Consequently, little systemic exposure and pharmacokinetics are expected and users can freely wash off and re-apply ethylhexyl methoxycrylene containing compounds as necessary.</pharmacodynamics>
  <mechanism-of-action>Ethylhexyl methoxycrylene is a photostabilizer with exceptionally low singlet (S1) and triplet (T1) energy states [A33135]. Given these properties, ethylhexyl methoxycrylene is capable of draining the singlet excited state reservoir of UV radiation excited molecules of various sunscreen agents [F103]. This action used to be considered impossible because molecules stay in the singlet excited state for a very short period of time - often as short as 13 one-thousandths of a billionth of a second [F103]. Ethylhexyl methoxycrylene, however, is a singlet quencher that dramatically reduces the flow of energy to the triplet escited state reservoir [F103]. As it quenches the singlet excited state, molecules do not have the chance to get to the triplet excited state reservoir and largely return to the ground state where they can continue functioning [F103]. In fact, this mechanism of action of ethylhexyl methoxycrylene is considered as being able to return UV filters to their ground states without absorbing sunlight [F104].&#13;
&#13;
Ultimately, because ethylhexyl methoxycrylene can work so quickly, it allows manufacturers to formulate products with combinations of sunscreen ingredients that used to be considered too photo-unstable to be effective [F103]. Moreover, ethylhexyl methoxycrylene is easily emulsified, and is suitable for use in lotions, creams, sprays, sticks, and gel formulations [F104].</mechanism-of-action>
  <toxicity>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal. Additionally, no ocular irritation, phototoxicity, dermal irritation, or allergic contact sensitization has been reported to any significant degree [L2847].</toxicity>
  <metabolism>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal.</metabolism>
  <absorption>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. At this time, however, studies demonstrate that the components of most commonly used sunscreens are likely absorbed into the skin at least to some extent - although penetration to deeper tissues and the cutaneous circulation remains limited [A33070]. Despite the extensive use of sunscreen products around the world, there have been few reports of adverse effects related to their use [A33070].</absorption>
  <half-life>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal.</half-life>
  <protein-binding>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal.</protein-binding>
  <route-of-elimination>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal.</route-of-elimination>
  <volume-of-distribution>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal.</volume-of-distribution>
  <clearance>Ethylhexyl methoxycrylene is reported as having little to no absorption through the skin [F101]. The systemic presence of the compound is consequently expected to be minimal.</clearance>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Almost Makeup SPF 15</name>
      <labeller>Asanuma Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>38001-800</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-11-09</started-marketing-on>
      <ended-marketing-on>2017-10-12</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Almost Makeup SPF 18</name>
      <labeller>Asanuma Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>38001-801</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sunscreen SPF30</name>
      <labeller>NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD</labeller>
      <ndc-id/>
      <ndc-product-code>47993-216</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-02-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Solastay S1</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Almost Makeup SPF 15</name>
      <ingredients>Ethylhexyl methoxycrylene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Sunscreen SPF30</name>
      <ingredients>Avobenzone + Benzophenone + Ethylhexyl methoxycrylene + Peg-100 stearate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Almost Makeup SPF 18</name>
      <ingredients>Ethylhexyl methoxycrylene + Titanium dioxide</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB11226.pdf?1527101034</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>6.19</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-5.6</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.09e-03 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>6.63</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>2-ethylhexyl 2-cyano-3-(4-methoxyphenyl)-3-phenylprop-2-enoate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>ethylhexyl methoxycrylene</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>391.511</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>391.214743798</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CCCCC(CC)COC(=O)C(C#N)=C(C1=CC=CC=C1)C1=CC=C(OC)C=C1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C25H29NO3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C25H29NO3/c1-4-6-10-19(5-2)18-29-25(27)23(17-26)24(20-11-8-7-9-12-20)21-13-15-22(28-3)16-14-21/h7-9,11-16,19H,4-6,10,18H2,1-3H3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>WAJCJDLRJVDSSD-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>59.32</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>125.05</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>44.49</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-4.8</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>52085894</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>